Global Auto-Injectors Market: Industry Status, Sales Outlook, Supply-Demand Analysis 2019-2028
Auto-injectors are medical devices designed for delivering a fixed dose of particular drug and are intended for self-administration by patients. Auto-injectors are gradually gaining demand for treating various indications such as anaphylaxis, multiple sclerosis, rheumatoid arthritis and others. Most auto-injectors are spring-loaded syringes, which make the procedure relatively simple. These instruments are specially made to avoid needle stick injury, anxiety, blood clots, and needle phobia among patients. The location for injecting a particular drug is dependent on the nature of the drug, however it is normally taken through any intramuscular route.
Factors driving growth of the global auto-injectors market includes rising incidences of anaphylactic shock, rising awareness of patients about auto-injectors coupled with rising preference for self-administration of injections. Auto-injectors provide inexpensive home medication, reduce dependency on healthcare professionals and time consumed at in-patient and out-patient care units, thereby fueling growth of the global auto-injectors market. In addition, factors such as rising geriatric population and high production of biologics are also contributing to growth of the global auto-injectors market.
Despite various advantages of auto-injectors, high prices of these injectors and availability of substitute products such as general injections and oral tablets may hamper growth of this market in the near future.
The global auto-injectors market has been segmented on the basis of product, design, application, and region.
Global auto-injectors market segmentation by product: Prefilled, Fillable. Global auto-injectors market segmentation by design: Standardized, Customized. Global auto-injectors market segmentation by application: Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others. Global auto-injectors market segmentation by distribution channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores,
North America is largest market for auto-injectors owing to increasing diabetes and anaphylaxis cases, and increasing production of biologics. The auto-injectors market is expected to witness fastest growth in Asia Pacific during the forecast period owing to increasing cases of anaphylaxis, increasing awareness about needle-stick injuries, rising healthcare expenditure, and growing geriatric population.
To Get Sample Copy of Report visit @ https://marketresearch.biz/report/auto-injectors-market/request-sample/
Key players operating in the global auto-injectors market include Mylan N.V., Antares Pharma Inc., Becton, Dickinson & Co., Eli Lilly and Company, Pfizer, Inc., Bayer AG, Novartis International AG, Bristol-Myer Squibb, Novartis AG, Amgen Inc. and Biogen Inc.
The insight analysis on research report provides:
– The evaluated growth rate together with size and market share over the forecast period 2019-2028.
– The primary factors estimated to drive the Market for the forecasting period 2019-2028.
– The major Global market regulatory bodies and what has been their business expanding strategy for leading so far.
– Influential trends shaping the growth probabilities of the Market.
In-depth and complete business outlook, market revenue study, business expansion strategies, and SWOT analysis of the major leading players have been served in the report. Vendors in the Worldwide market are focusing to explore their operations to developing regions. More, companies in the market are concentrating on innovation and standing their products at competitive prices. A detailed analysis of supply chain in the report will help readers to understand market clearly.